Traitement et prise en charge de la cholangite sclérosante ... - Afef

31. Broome U, Löfberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis:evidence for increased neoplastic potential. Hepatology 1995;22:1404-1408.32. Eaden JA, Mayberry JF. Colorectal cancer complicating ulcerative colitis: a review. Am JGastroenterol 2000;95:2710-2719.33. Kartheuser AH, Dozois RR, LaRusso NF, Wiesner RH, Ilstrup DM, Schleck CD. Comparison ofsurgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-analanastomosis versus Brooke ileostomy. Mayo Clin Proc 1996;71:748-756.34. Heathcote EJ. Management of primary biliary cirrhosis. Hepatology 2000;31:1005-1013.35. Angulo P, Therneau TM, Jorgensen RA, DeSotel CK, Egan KS, Dickson ER, Hay JE, Lindor KD.Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction ofprogression. J Hepatol 1998;29:729-735.36. Abu-Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, et al.Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg GynecolObstet 1993;177:335-344.37. Harrison J, McMaster P. The role of orthotopic liver transplantation in the management of sclerosingcholangitis. Hepatology 1994;20:14S-19S.38. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P,McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH. Minimal criteria for placement of adultson the liver transplant waiting list: a report of a national conference organized by the AmericanSociety of Transplant Physicians and the American Association for the Study of Liver Diseases. LiverTranspl Surg 1977;3:628-637.39. Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survivalin primary sclerosing cholangitis. Hepatology 1997;25:1049-1053.40. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M,Dicson ER. The relative role of the Child-Pugh classification and the Mayo natural history model inthe assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999;29:1643-1648.